JP2015502368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015502368A5 JP2015502368A5 JP2014547553A JP2014547553A JP2015502368A5 JP 2015502368 A5 JP2015502368 A5 JP 2015502368A5 JP 2014547553 A JP2014547553 A JP 2014547553A JP 2014547553 A JP2014547553 A JP 2014547553A JP 2015502368 A5 JP2015502368 A5 JP 2015502368A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- compound
- composition according
- leucine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161576720P | 2011-12-16 | 2011-12-16 | |
| US61/576,720 | 2011-12-16 | ||
| PCT/US2012/070190 WO2013090931A2 (en) | 2011-12-16 | 2012-12-17 | Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156321A Division JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015502368A JP2015502368A (ja) | 2015-01-22 |
| JP2015502368A5 true JP2015502368A5 (https=) | 2015-11-05 |
Family
ID=48613379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014547553A Withdrawn JP2015502368A (ja) | 2011-12-16 | 2012-12-17 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
| JP2017156321A Pending JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017156321A Pending JP2018024674A (ja) | 2011-12-16 | 2017-08-14 | 網膜の障害および疾患の治療のためのａｎｐ（心房性ナトリウム利尿ペプチド）、ｂｎｐ（脳性ナトリウム利尿ペプチド）およびｃｎｐ（ｃ型ナトリウム利尿ペプチド）−関連ペプチドならびにそれらの誘導体の方法および使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150045301A1 (https=) |
| EP (1) | EP2790714A4 (https=) |
| JP (2) | JP2015502368A (https=) |
| CN (2) | CN104039341A (https=) |
| CA (1) | CA2853204A1 (https=) |
| HK (1) | HK1202433A1 (https=) |
| WO (1) | WO2013090931A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106822182A (zh) * | 2016-12-27 | 2017-06-13 | 广州姿生生物科技有限公司 | 一种细胞提取物及其用途 |
| US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
| WO1987005330A1 (en) | 1986-03-07 | 1987-09-11 | Michel Louis Eugene Bergh | Method for enhancing glycoprotein stability |
| US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US5962406A (en) | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
| JPH10273450A (ja) * | 1997-03-27 | 1998-10-13 | Toagosei Co Ltd | 眼内血管新生性疾患治療薬 |
| KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
| AU2005227870A1 (en) * | 2004-02-17 | 2005-10-13 | University Of South Florida | Materials and methods for treatment of inflammatory and cell proliferation disorders |
| US20070049251A1 (en) | 2005-08-31 | 2007-03-01 | Mock Von A | Method and system for wireless communication in emergency situations |
| JP2010539002A (ja) * | 2007-09-11 | 2010-12-16 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | ウロジラチンの治療剤としての使用 |
| WO2009039982A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
| WO2009033690A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Bfgf (119-126) for therapeutic applications |
| KR20100056508A (ko) * | 2007-09-11 | 2010-05-27 | 몬도바이오테크 래보래토리즈 아게 | 폐렴 연쇄상 구균 감염의 치료를 위한 ｂｆｇｆ １－２４ 및 임의의 （ａｒｇ ８）바소프레신의 용도 |
| EP2224946B1 (en) * | 2007-12-28 | 2016-11-02 | Kalos Therapeutics, Inc. | Anti-proliferative compounds and their use |
| US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| WO2011038061A2 (en) * | 2009-09-25 | 2011-03-31 | Alcon Research, Ltd. | Novel npr-b agonists |
| WO2011075471A2 (en) * | 2009-12-18 | 2011-06-23 | Alcon Research, Ltd. | Novel npr-b agonists and methods of use for the treatment of c-type natriuretic peptide-mediated disorders |
-
2012
- 2012-12-17 HK HK15103021.0A patent/HK1202433A1/xx unknown
- 2012-12-17 CA CA2853204A patent/CA2853204A1/en not_active Abandoned
- 2012-12-17 US US14/365,517 patent/US20150045301A1/en not_active Abandoned
- 2012-12-17 JP JP2014547553A patent/JP2015502368A/ja not_active Withdrawn
- 2012-12-17 EP EP12858180.8A patent/EP2790714A4/en not_active Withdrawn
- 2012-12-17 CN CN201280062142.XA patent/CN104039341A/zh active Pending
- 2012-12-17 WO PCT/US2012/070190 patent/WO2013090931A2/en not_active Ceased
- 2012-12-17 CN CN201810139954.9A patent/CN108653715A/zh active Pending
-
2017
- 2017-08-14 JP JP2017156321A patent/JP2018024674A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10583125B2 (en) | Method for treating neurodegenerative diseases | |
| Sheibani et al. | Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization | |
| JP6666899B2 (ja) | Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法 | |
| JP7726791B2 (ja) | 補体活性を調節するための組成物及び方法 | |
| JP7280619B2 (ja) | ペプチド組成物 | |
| JP2014511858A5 (https=) | ||
| ES2755053T3 (es) | Composición para el tratamiento de lesiones cerebrales | |
| JP2016523274A (ja) | 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用 | |
| JP7423070B2 (ja) | 増加した溶解度および改善された薬物動態特性を有するコンプスタチンアナログ | |
| US20200222548A1 (en) | Synthetic bioconjugates | |
| KR20200026918A (ko) | 화학적으로 변형된 백본을 갖는 생체접합체 | |
| CN116917482A (zh) | 嵌合蛋白和治疗中枢神经系统疾病的方法 | |
| Jiang et al. | Eyedrop delivery of therapeutic proteins with zwitterionic polymers to treat dry age-related macular degeneration | |
| AR079683A1 (es) | Formulacion topica oftalmica de peptidos | |
| RU2744878C2 (ru) | Ингибиторы дипептидилпептидазы-4 для местного офтальмологического лечения нейродегенеративных заболеваний сетчатки | |
| JP2015502368A5 (https=) | ||
| JP2018536650A5 (https=) | ||
| WO2019048852A1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES | |
| WO2008075365A1 (en) | Compositions and methods for treatment of age related degeneration of the retina | |
| US9913877B2 (en) | Methods and compositions for the treatment of axonal and neuronal degeneration | |
| JP6046060B2 (ja) | エイズの治療のための、ポリアニオン性ポリペプチドと結合しているｃｄ４受容体由来ペプチドを含んでなる新規コンジュゲート分子 | |
| WO2025022842A1 (ja) | ドライアイの治療剤又は予防剤 | |
| JP2023504731A (ja) | タウオパチーを処置するためのペプチド組成物及び方法 | |
| KR102023827B1 (ko) | 안구 건조증 질환의 치료 및/또는 예방을 위한 짧은 합성 펩티드의 용도 | |
| WO2019048854A1 (en) | TREATMENT OF NEURODEGENERATIVE DISEASES |